touchPODCAST

Epizódy

• 
  Empowering choice in HIV care: Moving beyond daily pills to person‐centred ART strategies 15.09.2026 35min

  touchEXPERT FOCUS for touchINFECTIOUS DISEASES Listen to a series of short interviews with three leading experts discussing preference-sensitive care for people living with HIV. Faculty consider the evolving landscape of simplified ART options, including long-acting injectable regimens, and provide practical strategies to align treatment choices with individual goals and preferences. They also discuss the value and feasibility of integrating patient-reported outcome assessments into routine care for people living with HIV. The experts: Prof. Chloe Orkin – Barts Health NHS Trust and Queen Mary University of London, UK Dr. Brenda Crabtree-Ramirez – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico Prof. Jürgen Rockstroh – HIV Outpatient Clinic, University of Bonn, Bonn, Germany This touchPODCAST is for healthcare professionals outside of the UK. This activity is funded by an independent medical education grant from ViiV Healthcare. This activity is provided by touchIME. For further information visit our website: touchINFECTIOUSDISEASES.com
• 
  Recognizing MOGAD: Defining a distinct demyelinating disease 11.09.2026 17min

  touchEXPERT FOCUS for touchNEUROLOGY, touchIMMUNOLOGY, touchOPHTHALMOLOGY    Dr. Eoin Flanagan shares his expert insights on myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and how to distinguish it from other demyelinating diseases like multiple sclerosis (MS) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-positive NMOSD). As part of the interview, Dr. Flanagan describes MOGAD’s pathogenesis and explains how to achieve an early accurate diagnosis using the latest diagnostic frameworks.   The expert Dr. Eoin Flanagan, Mayo Clinic, Rochester, MN, USA   This activity is funded by an independent medical education grant from UCB. It is jointly provided by USF Health and touchIME.   This touchPODCAST is for healthcare professionals in the USA only.   For further information, please visit our websites: www.touchNEUROLOGY.com, www.touchIMMUNOLOGY.com, www.touchOPHTHALMOLOGY.com
• 
  Systemic mastocytosis: Making the right decisions at the right time (video 3) 02.09.2026 16min

  touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary care is needed to effectively manage patients with systemic mastocytosis.   The multidisciplinary team Allergist/Immunologist: Dr. Cem Akin, University of Michigan Health, Ann Arbor, MI, USA Allergist/Immunologist: Dr. Theo Gülen, Karolinska University Hospital, Stockholm, Sweden Hematologist: Dr. Tsewang Tashi, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an unrestricted independent medical education grant from BluePrint Medicines Corporation.  This activity is jointly provided by USF Health and touchIME.touchIME is an EBAC® accredited provider.For further information visit our website: www.touchHEMATOLOGY.com, www.touchIMMUNOLOGY.com, www.touchDERMA.com, or www.touchONCOLOGY.com
• 
  Systemic mastocytosis: Making the right decisions at the right time (video 2) 02.09.2026 16min

  touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary care is needed to effectively manage patients with systemic mastocytosis.   The multidisciplinary team Allergist/Immunologist: Dr. Cem Akin, University of Michigan Health, Ann Arbor, MI, USA Allergist/Immunologist: Dr. Theo Gülen, Karolinska University Hospital, Stockholm, Sweden Hematologist: Dr. Tsewang Tashi, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an unrestricted independent medical education grant from BluePrint Medicines Corporation.  This activity is jointly provided by USF Health and touchIME.touchIME is an EBAC® accredited provider.For further information visit our website: www.touchHEMATOLOGY.com, www.touchIMMUNOLOGY.com, www.touchDERMA.com, or www.touchONCOLOGY.com
• 
  Systemic mastocytosis: Making the right decisions at the right time (video 1) 02.09.2026 14min

  touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary care is needed to effectively manage patients with systemic mastocytosis.   The multidisciplinary team Allergist/Immunologist: Dr. Cem Akin, University of Michigan Health, Ann Arbor, MI, USA Dermatologist: Dr. Lauren Madigan, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an unrestricted independent medical education grant from BluePrint Medicines Corporation.  This activity is jointly provided by USF Health and touchIME.touchIME is an EBAC® accredited provider.For further information visit our website: www.touchHEMATOLOGY.com, www.touchIMMUNOLOGY.com, www.touchDERMA.com, or www.touchONCOLOGY.com
• 
  Immunotherapy in R/M NPC: Interpreting the evidence and individualizing care 17.08.2026 20min

  touchEXPERT FOCUS for touchONCOLOGY Listen to an interview with Dr. Deborah Wong as she shares her expert insights on the current evidence and latest guidelines for immune checkpoint inhibitor (ICIs) use in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). She also discusses how patient- and disease-specific factors can inform individualized treatment decisions. The expert:Dr. Deborah Wong, University of California, Los Angeles (UCLA), CA, USA   This activity is funded by an independent medical education grant from Coherus Oncology, Inc. This activity is jointly provided by USF Health and touchIME. This touchPODCAST is for HCPs in the USA only.   For further information, please visit our website: www.touchONCOLOGY.com  
• 
  Chronic and/or recurrent postoperative intraocular inflammation: Improving diagnosis, classification and management 13.08.2026 40min

  touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with three leading experts discussing chronic and/or recurrent postoperative intraocular inflammation. The faculty explore how to identify patients with persistent disease, differentiate infectious, mechanical, and non-infectious etiologies, and use multimodal imaging to evaluate underlying causes and posterior segment involvement. They also discuss how diagnostic findings guide treatment decisions, when to reassess or escalate management, and practical approaches to achieving durable disease control through individualized, etiology-driven treatment strategies. The experts: Dr. Aniruddha Agarwal—Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates Prof. Marion Munk—Augenarzt-Praxisgemeinschaft Gutblick AG, Pfäffikon, Switzerland; University Hospital Bern, Switzerland; Northwestern University, Chicago, IL, USA Prof. Francesco Bandello—University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy This touchPODCAST is for healthcare professionals outside of the UK and USA. This activity is supported by an independent medical education grant from Alimera Sciences Europe Ltd. This activity is jointly provided by Partners for Advancing Clinical Education and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: touchophthalmologyime.org
• 
  Advancing the management of HER2-altered NSCLC: Interpreting the latest clinical trial data 13.08.2026 49min

  touchCONGRESS for touchONCOLOGY and touchRESPIRATORY   Listen to thoracic oncologist Dr. Julia Rotow (USA) review the latest HER2-targeted therapy data for NSCLC from the 2026 ASCO Annual Meeting. Alongside Prof. David Planchard (France) and Dr. Misako Nagasaka (USA), they discuss these findings in the context of evidence presented at recent international congresses and their clinical implications for managing HER2-altered NSCLC. The experts Dr. Julia Rotow, Dana-Farber Cancer Institute, Boston, MA, USA Prof. David Planchard, Institut Gustave Roussy, Paris, France Dr. Misako Nagasaka, University of California, Irvine (UCI) Health Chao Family Comprehensive Cancer Center, Orange, CA, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from AstraZeneca.  This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: www.touchoncology.com or www.touchrespiratory.com
• 
  Where we are now in PDAC care: Clinical insights, emerging biomarkers and evolving therapeutic strategies 05.08.2026 44min

  touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss how biomarker-driven insights and emerging therapies are shaping treatment decisions in PDAC. They cover early testing strategies, novel targeted and immunologic therapies, and evidence-based treatment sequencing across the disease continuum. The experts: Dr. Allyson Ocean - Weill Cornell Medicine, New York, NY, USA Prof. Thierry Conroy - Institut de Cancérologie de Lorraine, University of Lorraine Nancy, France Dr. Eileen O'Reilly - Memorial Sloan Kettering Cancer Center, New York NY, United States This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Revolution Medicines. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com
• 
  Reimagining Alzheimer’s care: Harnessing subcutaneous therapies and early diagnostic innovation to transform patient lives 29.07.2026 45min

  touchPANEL DISCUSSION for touchNEUROLOGY Listen to three leading experts discussing the recent advances in timely, biomarker-guided diagnosis and how current and emerging intravenous and subcutaneous disease-modifying therapies may impact clinical practice in the future and enable treatment personalization based on the underlying pathology of Alzheimer’s disease The experts Dr Soo Borson, Keck USC School of Medicine, Los Angeles, CA, USA Dr Clifford Singer, Northern Light Acadia Hospital, Bangor, ME, USA Dr Frederick Ketchum, University of Wisconsin-Madison, Madison, WI, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Eisai Inc. Jointly provided by Partners for Advancing Clinical Education and touchIME in collaboration with the Gerontological Society of America (GSA). For further information, visit: www.touchNEUROLOGY.com
• 
  Building confidence in geographic atrophy care: From diagnosis to dialogue 27.07.2026 38min

  touchIN CONVERSATION for touchOPHTHALMOLOGYAs treatment options for geographic atrophy continue to evolve, clinicians face new opportunities and challenges in diagnosis, treatment planning, and patient engagement. Join retina specialists Dr. Samuel Minaker and Dr. Priya Vakharia for a peer-to-peer discussion on geographic atrophy care, covering the patient journey from diagnosis to effective patient management and communication.The experts Dr. Samuel Minaker, Tyler Retina Consultants, Tyler, TX, USA Dr. Priya Vakharia, Retina Vitreous Associates of Florida, Tampa, FL, USA This touchPODCAST is for HCPs in the USA only. This activity is supported by an independent medical education grant from Apellis, a Subsidiary of Biogen.  Jointly provided by Partners for Advancing Clinical Education and touchIME. For further information visit our website: www.touchOPHTHALMOLOGY.com
• 
  Beyond ATTR in Japan: Accurate diagnosis of cardiac AL in the TTR stabilizer era (in Japanese) 22.07.2026 29min

  touchEXPERT FOCUS for touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY Listen to a series of interviews with Dr. Toru Kubo as he shares his expert insights into real-world diagnostic pitfalls in cardiac amyloid light-chain amyloidosis (AL), stepwise application of the Japanese Circulation Society (JCS) diagnostic algorithm to achieve an accurate diagnosis of cardiac AL, and timely engagement of hematology and multidisciplinary discussion around transthyretin (TTR) stabilizer initiation.The expert: Dr. Toru Kubo, Kochi Medical School, Kochi University, Japan This touchPODCAST is recorded in Japanese and is intended for HCPs in Japan.   This activity is supported by an independent educational grant from Alexion Pharma GmbH. Jointly provided by Partners for Advancing Clinical Education and TouchIME. For further information, please visit our websites: touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY
• 
  Targeting pathogenic mechanisms in gMG: From complement- and FcRn-directed therapies to B- and T-cell-targeted approaches 09.07.2026 40min

  touchTALKS for touchNEUROLOGY Listen to an autoimmune neuromuscular disease expert review the unmet needs for patients with generalized myasthenia gravis and explain how emerging targeted therapies address underlying disease mechanisms to improve patient outcomes. The expert Dr. Richard Nowak, Yale School of Medicine, New Haven, CT, USA This touchPODCAST is for healthcare professionals outside of the UK. This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.    For further information, visit our website: https://touchneurologyime.org/targeted-therapies-in-gmg/  
• 
  The art and science of presbyopia-correcting intraocular lens selection: From preoperative planning to patient satisfaction 09.07.2026 38min

  touchCASES for touchOPHTHALMOLOGYListen to two experts as they discuss three cases illustrating the art and science of presbyopia-correcting intraocular lens (IOL) selection, from preoperative planning to patient satisfaction. They examine key decision points from preoperative assessment and clinical workup to presbyopia-correcting IOL selection in routine and complex cases.The experts: Dr. Dagny Zhu, Zhu Vision - Modern Laser & Cataract Eye Surgery, Orange, CA, USA Prof. Renato Ambrósio Jr., Federal University of the State of Rio de Janeiro, Brazil This activity is for HCPs in the USA, Canada, and Latin America. This activity is funded by an independent medical education grant from Alcon Vision, LLC. The activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchOPHTHALMOLOGY.com
• 
  Unraveling the cortisol connection: Hard-to-control hypertension and hyperglycemia 08.07.2026 39min

  touchTALKS for touchENDOCRINOLOGY Listen to Dr. Richard Auchus, as he describes how hypercortisolism can lead to hyperglycemia and hypertension, and discusses how to recognize, screen, and manage hypercortisolism in at-risk patient populations. The expert Dr Richard J. Auchus, University of Michigan, Ann Arbor, MI, USA. This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Corcept Therapeutics Incorporated. This activity is jointly provided by Partners for Advancing Clinical Education and touchIME. For further information visit our website: www.touchENDOCRINOLOGY.com
• 
  Reducing attrition and maximizing ADC impact in metastatic breast cancer 07.07.2026 39min

  touchIN CONVERSATION for touchONCOLOGY Identifying patients at risk of treatment attrition is an important part of treatment decision-making, as these patients may miss opportunities to receive subsequent treatments that could improve survival and quality of life. Listen to breast cancer experts consider the impact of treatment attrition in metastatic breast cancer and review evidence supporting the earlier integration of antibody–drug conjugates in the treatment pathway.   The experts Prof. Fatima Cardoso, Centre Antoine Lacassagne and Advanced Breast Cance (ABC) Global Alliance, Nice, France Asst. Prof. Domen Ribnikar, Institute of Oncology Ljubljana, Slovenia   This touchPODCAST is for HCPs outside of the UK.   This activity is supported by an independent medical education grant from Daiichi Sankyo Europe GmbH/AstraZeneca. touchIME is an EBAC® accredited provider.   For further information visit our website: www.touchONCOLOGY.com
• 
  The art of diagnosing CIDP: Strengthening diagnostic confidence 06.07.2026 37min

  touchCASES for touchNEUROLOGY Hear from two European experts as they discuss how to strengthen diagnostic confidence in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Through three patient cases, they address how to recognize and differentiate CIDP variants from other polyneuropathies and consider how key diagnostic criteria can be applied to reinforce diagnostic confidence. The experts: Prof. Dr. Claudia Sommer, University of Würzburg, Würzburg, Germany Dr. Filip Eftimov, Amsterdam UMC, Amsterdam, The Netherlands This activity is funded by an independent medical education grant from Sanofi. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. This touchPODCAST is for HCPs outside of the UK. For further information, visit our website: www.touchNEUROLOGY.com
• 
  The key to ketoacidosis: Unlocking the potential for better DKA monitoring and detection 06.07.2026 34min

  touchEXPERT FOCUS for touchENDOCRINOLOGY Listen to a series of interviews with Dr. Eden Miller who will provide her expert insights into the recognition of typical and euglycemic diabetic ketoacidosis (DKA), the current and emerging ketone monitoring methods, including continuous ketone monitoring and the importance of optimizing patient and caregiver education to reduce preventable DKA events and hospitalizations. The expert: Dr. Eden Miller, Diabetes and Obesity Care, Bend, OR, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc.   The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.   For further information visit our website: www.touchENDOCRINOLOGY.com
• 
  Optimizing outcomes in advanced endometrial carcinoma: Navigating guidelines, biomarker-driven immunotherapy and irAE management 15.06.2026 36min

  touchCASES for touchONCOLOGY Join two international experts as they walk through three real-world patient stories, showing how molecular testing shapes treatment choices in advanced endometrial cancer and how immune-related side effects can be recognized and managed in everyday practice.      The experts: Dr Nicoletta Colombo, European Institute of Oncology, Milan, Italy Dr Ilaria Colombo, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland This activity is supported by an independent educational grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: www.touchONCOLOGY.com
• 
  Personalizing cataract surgery: From pre-operative precision to functional vision outcomes 21.05.2026 33min

  touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with a leading expert in cataract surgery. Dr Filomena Ribeiro shares insights on the latest advances in pre-operative assessment, AI-enhanced IOL power calculation and functional depth-of-field (DOFi)-based lens selection, as well as emerging IOL materials and technologies. She also provides practical guidance on patient communication strategies to support consistent, patient-centred refractive outcomes. The expert: Dr Filomena Ribeiro, Hospital da Luz Lisboa, University of Lisbon and Catholic University of Portugal, Lisbon, Portugal This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Alcon Eye Care UK Limited. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchophthalmologyime.org/personalizing-cataract-surgery-from-pre-op-precision-to-functional-vision-outcomes/